THE ORGANIZATION HAS BEEN ESTABLISHED TO HARVEST, PROCESS, AND UTILIZE UMBILICAL CORD BLOOD ("UCB") STEM CELLS FOR CLINICAL TRANSPLANTATION, MEDICAL RESEARCH, AND DISTRIBUTION, AND TO PROVIDE EDUCATION TO PHYSICIANS AND THE PUBLIC AT LARGE ON ADVANCES IN THE UTILIZATION OF UCB-DERIVED STEM CELLS FOR THE TREATMENT OF CANCER AND OTHER DISEASES.
Geographies
Not indicated
Dates
Jan 1, 2022 – Dec 31, 2022
Source
990
No causes provided
No populations provided
–
$4.4M
Cell Therapeutics Research
BEGINNING IN 2014, THE ORGANIZATION PERFORMS LABORATORY RESEARCH IN CELL THERAPEUTICS WITH FOUR STUDIES CURRENTLY IN PROGRESS.
Geographies
Not indicated
Dates
Jan 1, 2022 – Dec 31, 2022
Source
990
No causes provided
No populations provided
–
$782.2K
Cell Therapy Incubator
IN 2020, THE CORD BLOOD CENTER ESTABLISHED A CELL THERAPY INCUBATOR TO OFFER NEW TECHNOLOGIES FOR CELL PROCESSING AND DISTRIBUTE CORD BLOOD BASED PRODUCTS.